Cargando…
Immune‐related dermatitis during combined treatment with pembrolizumab and axitinib in a patient with metastatic renal cell\x92carcinoma with stasis dermatitis
INTRODUCTION: The combination of pembrolizumab and axitinib has recently been approved as a first‐line treatment for previously untreated metastatic renal cell carcinoma. However, immune‐related adverse events are not well known. CASE PRESENTATION: A 65‐year‐old male was diagnosed with renal cell ca...
Autores principales: | Imai, Shunsuke, Nakamura, Masaki, Chujo, Satomi, Ooki, Ryousuke, Inoue, Yasushi, Horiuchi, Hajime, Morikawa, Teppei, Uchino, Keita, Igarashi, Atsuyuki, Shiga, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560444/ https://www.ncbi.nlm.nih.gov/pubmed/34755064 http://dx.doi.org/10.1002/iju5.12356 |
Ejemplares similares
-
Clinical Psoriasiform Dermatitis Following Dupilumab Use for Autoeczematization Secondary to Chronic Stasis Dermatitis
por: Schrom, Kory P, et al.
Publicado: (2020) -
Treatment of stasis dermatitis using aminaphtone: a case series
por: de Godoy, José Maria Pereira
Publicado: (2010) -
Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management
por: Yosipovitch, Gil, et al.
Publicado: (2023) -
Pembrolizumab-induced lichenoid dermatitis treated with dupilumab
por: Park, Jonathan J., et al.
Publicado: (2023) -
Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension
por: Silverberg, Jonathan, et al.
Publicado: (2023)